Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Numerous number of evidences show that high on-treatment platelet reactivity is a well-known risk factor for adverse events in patients after percutaneous coronary intervention (PCI). Controversial situations still exist regarding the effectiveness of tailoring antiplatelet therapy according to plat...

Cijeli opis

Bibliografski detalji

Glavni autori:	Zhenhua Xing, Liang Tang, Zhaowei Zhu, Jiabing Huang, Xiaofan Peng, Xinqun Hu
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2018-08-01
Serija:	Platelets
Teme:	all-cause mortality major adverse cardiac events (mace) major bleeding events meta-analysis percutaneous coronary intervention (pci) platelet reactivity
Online pristup:	http://dx.doi.org/10.1080/09537104.2017.1349306
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!